| 1 |
24677340 | Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity. | 2014 Mar 21 |
1 |
| 2 |
11306049 | Three different stable human breast adenocarcinoma sublines that overexpress ALDH3A1 and certain other enzymes, apparently as a consequence of constitutively upregulated gene transcription mediated by transactivated EpREs (electrophile responsive elements) present in the 5'-upstream regions of these genes. | 2001 Jan 30 |
1 |
| 3 |
11320670 | Primary breast tumor levels of suspected molecular determinants of cellular sensitivity to cyclophosphamide, ifosfamide, and certain other anticancer agents as predictors of paired metastatic tumor levels of these determinants. Rational individualization of cancer chemotherapeutic regimens. | 2001 Mar |
1 |
| 4 |
10856427 | Inactivation of aldophosphamide by human aldehyde dehydrogenase isozyme 3. | 2000 Aug 1 |
3 |
| 5 |
10469894 | Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines. | 1999 Aug |
2 |
| 6 |
8654195 | Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide. | 1995 Oct |
6 |